235
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of leptin levels in serum as a biomarker for suicide behavior: systematic review and meta-analysis

, , , , , , & show all
Pages 49-55 | Received 21 Jan 2019, Accepted 14 Feb 2020, Published online: 28 Feb 2020

References

  • Atmaca M, Kuloglu M, Tezcan E, et al. Serum cholesterol and leptin levels in patients with borderline personality disorder. Neuropsychobiology. 2002;45(4):167–171.
  • Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand. 2003;108(3):208–214.
  • Bartoli F, Di Brita C, Crocamo C, et al. Lipid profile and suicide attempt in bipolar disorder: a meta-analysis of published and unpublished data. Prog Neuropsychopharmacol Biol Psychiatry. 2017;79(Pt B):90–95.
  • Sudol K, Mann JJ. Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep. 2017;19(6):31.
  • Marini S, Vellante F, Matarazzo I, et al. Inflammatory markers and suicidal attempts in depressed patients: a review. Int J Immunopathol Pharmacol. 2016;29(4):583–594.
  • da Graca Cantarelli M, Nardin P, Buffon A, et al. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord. 2015;172:403–409.
  • Eikelis N, Esler M, Barton D, et al. Reduced brain leptin in patients with major depressive disorder and in suicide victims. Mol Psychiatry. 2006;11(9):800–801.
  • Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Res. 2008;158(1):87–91.
  • Vancampfort D, Vansteelandt K, Correll CU, et al. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry. 2013;170(3):265–274.
  • Gomez-Peralta TG, Gonzalez-Castro TB, Fresan A, et al. Risk factors and prevalence of suicide attempt in patients with type 2 diabetes in the Mexican population. Int J Environ Res Public Health. 2018;15(6):1–10.
  • Penninx B, Lange S. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63–73.
  • Shakeri J, Farnia V, Valinia K, et al. The relationship between lifetime suicide attempts, serum lipid levels, and metabolic syndrome in patients with bipolar disorders. Int J Psychiatry Clin Pract. 2015;19(2):124–131.
  • Lalovic A, Klempan T, Sequeira A, et al. Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers. J Affect Disord. 2010;120(1-3):24–31.
  • Papadopoulou A, Douzenis A, Christodoulou C, et al. Body mass index and plasma leptin in psychiatric suicide attempters. Neuro Endocrinol Lett. 2017;38(5):375–380.
  • Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role for leptin. Front Physiol. 2018;9:640.
  • Atmaca M, Kuloglu M, Tezcan E, et al. Serum leptin and cholesterol values in suicide attempters. Neuropsychobiology. 2002;45(3):124–127.
  • Westling S, Ahren B, Traskman-Bendz L, et al. Low CSF leptin in female suicide attempters with major depression. J Affect Disord. 2004;81(1):41–48.
  • Wells GA, Shea B, O’Connel D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2018. [cited 2018 03/02/2018]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • Borenstein M, Higgins JP, Hedges LV, et al. Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity. Res Syn Meth. 2017;8(1):5–18.
  • González-Castro TB, Salas-Magaña M, Juárez-Rojop IE, et al. Exploring the association between BDNF Val66Met polymorphism and suicidal behavior: meta-analysis and systematic review. J Psychiatr Res. 2017;94:208–217.
  • Salas-Magana M, Tovilla-Zarate CA, Gonzalez-Castro TB, et al. Decrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: a systematic review and meta-analysis. Brain Behav. 2017;7(6):e00706.
  • Zhou F, Chen S. Effects of gender and other confounding factors on leptin concentrations in Alzheimer’s disease: evidence from the combined analysis of 27 case-control studies. J Alzheimer’s Dis. 2018;62(1):477–486.
  • Farias DR, Pinto T. D J P, Teofilo MMA, et al. Prevalence of psychiatric disorders in the first trimester of pregnancy and factors associated with current suicide risk. Psychiatry Res. 2013;210(3):962–968.
  • Fernandes BS, Dash S, Jacka F, et al. Leptin in bipolar disorder: a systematic review and meta-analysis. Eur Psychiatry 2016;35:1–7.
  • Akgun S, Koken T, Kahraman A. Evaluation of adiponectin and leptin levels and oxidative stress in bipolar disorder patients with metabolic syndrome treated by valproic acid. J Psychopharmacol. 2017;31(11):1453–1459.
  • Rosso G, Cattaneo A, Zanardini R, et al. Glucose metabolism alterations in patients with bipolar disorder. J Affect Disord. 2015;184:293–298.
  • Stubbs B, Wang AK, Vancampfort D, et al. Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis. Psychoneuroendocrinology. 2016;63:144–154.
  • Nurjono M, Neelamekam S, Lee J. Serum leptin and its relationship with psychopathology in schizophrenia. Psychoneuroendocrinology. 2014;50:149–154.
  • Lai KSP, Liu CS, Rau A, et al. Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry. 2017;88(10):876–882.
  • Pawlak D, Domaniewski T, Znorko B, et al. The impact of peripheral serotonin on leptin-brain serotonin axis, bone metabolism and strength in growing rats with experimental chronic kidney disease. Bone. 2017;105:1–10.
  • Lima LB, Metzger M, Furigo IC, et al. Leptin receptor-positive and leptin receptor-negative proopiomelanocortin neurons innervate an identical set of brain structures. Brain Res. 2016;1646:366–376.
  • Maioli S, Lodeiro M, Merino-Serrais P, et al. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer’s disease. Aging Cell. 2015;14(1):122–129.
  • Farr OM, Tsoukas MA, Mantzoros CS. Leptin and the brain: influences on brain development, cognitive functioning and psychiatric disorders. Metabolism. 2015;64(1):114–130.
  • Kořínková L, Holubová M, Neprašová B, et al. Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice. J Mol Endocrinol. 2020;64(2):77–90.
  • Kusuhara M, Maruyama K, Ishii H, et al. A fragrant environment containing α-pinene suppresses tumor growth in mice by modulating the hypothalamus/sympathetic nerve/leptin axis and immune system. Integr Cancer Ther. 2019;18. DOI:10.1177/1534735419845139
  • Zepf FD, Dingerkus VLS, Helmbold K, et al. Effects of a short-term reduction in brain serotonin synthesis on the availability of the soluble leptin receptor in healthy women. J Neural Transm. 2015;122(3):343–348.
  • Ghasemi A, Seifi M, Baybordi F, et al. Association between serotonin 2A receptor genetic variations, stressful life events and suicide. Gene. 2018;658:191–197.
  • Gonzalez-Castro TB, Hernandez-Diaz Y, Juarez-Rojop IE, et al. The role of the Cys23Ser (rs6318) polymorphism of the HTR2C gene in suicidal behavior: systematic review and meta-analysis. Psychiatric Genet. 2017;27(6):199–209.
  • Carrard A, Salzmann A, Malafosse A, et al. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affect Disord. 2011;132(3):450–453.
  • Lalovic A, Sequeira A, DeGuzman R, et al. Investigation of completed suicide and genes involved in cholesterol metabolism. J Affect Disord. 2004;79(1-3):25–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.